# Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine

> **NCT00001533** · PHASE1 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 25 (—)

## Conditions studied

- Anemia
- Leukemia, T-Cell
- Lymphocytosis
- Neutropenia
- Thrombocytopenia

## Interventions

- **DRUG:** cyclosporine

## Key facts

- **NCT ID:** NCT00001533
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-09
- **Primary completion:** —
- **Final completion:** 2000-09
- **Target enrollment:** 25 (—)
- **Last updated:** 2006-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001533, "Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00001533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*